Diamond Hill Bets on BioLife Solutions' (BLFS) High Switching Cost
Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Small Cap Strategy”. The letter can be downloaded here.
Biolife Solutions Inc (BLFS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Magnetar Capital Alec Litowitz And Ross Laser | 1,094,482 | $42,520,626 | 0.42% | |
| 2. | Water Island Capital John Orrico | 716,005 | $27,816,794 | 2.76% | |
| 3. | Soros Fund Management George Soros | 671,025 | $26,069,321 | 0.31% | |
| 4. | Royce & Associates Chuck Royce | 371,154 | $14,419,333 | -41% | 0.13% |
| 5. | Ranger Investment Management Conrad Doenges (Cio) | 238,415 | $9,262,423 | -1% | 0.87% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.19 | 927,165 | $10,374,976.35 | 8,557,165 | 2023-10-19 | Filing | |
| $13.20 | 58,465 | $771,743.85 | 7,630,000 | 2023-08-09 | Filing | |
| $21.86 | 24,973 | $545,789.91 | 150,000 | 2023-05-22 | Filing | |
| $22.55 | 50,000 | $1,127,430.00 | 125,027 | 2023-05-19 | Filing | |
| $21.76 | 30,000 | $652,692.00 | 75,027 | 2023-05-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.70 | 650,000 | $15,405,000.00 | 4,757,165 | 2026-05-21 | Filing | |
| $23.70 | 250,000 | $5,925,000.00 | 5,407,165 | 2026-05-20 | Filing | |
| $22.65 | 300,000 | $6,795,000.00 | 5,657,165 | 2026-05-19 | Filing | |
| $19.17 | 2,577 | $49,401.09 | 108,758 | 2026-03-23 | Filing | |
| $20.00 | 500 | $10,000.00 | 113,242 | 2026-03-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,673,770 | $259,275,964 | 0% | |
| 2. | 1,995,461 | $77,523,660 | 0% | |
| 3. | 1,652,823 | $64,212,174 | 0% | |
| 4. | 1,425,085 | $55,364,552 | 2.67% | |
| 5. | 1,245,629 | $48,392,688 | 0% |
News See All
What Makes BioLife Solutions (BLFS) a Compelling Long-Term Hold?
Prosper Stars & Stripes, a long/short equity fund, recently released its first-quarter 2026 investor letter. A copy of the letter is available to download here.
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2026 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2026 Earnings Call Transcript May 8, 2026 Operator: Good afternoon, ladies and gentlemen, and thank you for standing by.
BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2025 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2025 Earnings Call Transcript February 26, 2026BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $0.07267, expectations were $-0.02.
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2025 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2025 Earnings Call Transcript November 6, 2025 Operator: Good afternoon, ladies and gentlemen, and thank you for standing by.
BioLife Solutions, Inc. (NASDAQ:BLFS) Q2 2025 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ:BLFS) Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Good afternoon, ladies and gentlemen, and thank you for standing by.
H.C. Wainwright Maintains Buy rating on BioLife (BLFS) Stock
On May 27, H.C. Wainwright reaffirmed its Buy rating on BioLife Solutions, Inc. (NASDAQ:BLFS) while keeping the price target the same at $30.
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2025 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2025 Earnings Call Transcript May 8, 2025 Operator: Good afternoon, ladies and gentlemen, and thank you for standing by.
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2024 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good afternoon, ladies and gentlemen, and thank you for standing by.
BioLife Solutions (BLFS) Surpassed Revenue and Earnings-Per-Share Expectations in Q2
Conestoga Capital Advisors, an asset management company, released its “Micro-Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.